Embryonic pig pancreatic tissue for the treatment of diabetes: Potential role of immune suppression with off-the-shelf third-party regulatory T cells

Transplantation

Volumn 91, Issue 4, 2011, Pages 398-405

  Tchorsh Yutsis, Dalit ^a   Zlotnikov Klionsky, Yael ^a   Bachar Lustig, Esther ^a   Aronovich, Anna ^a   Feine, Ilan ^a   Shezen, Elias ^a   Rosen, Chava ^a   Bitcover, Rivka ^a   Eventov Friedman, Smadar ^a   Katchman, Helena ^a   Zangi, Lior ^a   Tal, Orna ^a   Cohen, Sivan ^a   Reisner, Yair ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Pancreas; T regulatory cells; Transplantation; Xenotransplanataion

Indexed keywords

FINGOLIMOD; RAPAMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; C57BL 6 MOUSE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CONTROLLED STUDY; DIABETES MELLITUS; EMBRYONAL TISSUE; EMBRYONIC PIG PANCREATIC TISSUE; ENGRAFTMENT; EX VIVO STUDY; FREEZE THAWING; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LYMPH NODE; MOUSE; NONHUMAN; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SWINE; TISSUE GROWTH; XENOGRAFT;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DIABETES MELLITUS; EMBRYO, MAMMALIAN; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE AGENTS; INSULIN; MICE; MICE, INBRED C57BL; PANCREAS TRANSPLANTATION; PROPYLENE GLYCOLS; SIROLIMUS; SPHINGOSINE; SWINE; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION TOLERANCE; TRANSPLANTATION, HETEROLOGOUS;

EID: 79951683059     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318204be15     Document Type: Article

References (31)

1. Dekel B, Burakova T, Marcus H, et al. Engraftment of human kidney tissue in rat radiation chimera: I. A new model of human kidney allo-graft rejection. Transplantation 1997; 64: 1541.
2. Dekel B, Burakova T,Arditti FD,etal. Human and porcine early kidney precursors as a new source for transplantation. Nat Med 2003; 9: 53.
3. Foglia RP, DiPreta J, Statter MB, et al. Fetal allograft survival in immu-nocompetent recipients is age dependent and organ specific. Ann Surg 1986; 204: 402.
4. Hammerman MR. Windows of opportunity for organogenesis. Transplant Immunol 2005; 15: 1.
5. Metzger R, Parasta A, Joppich I, et al. Organ-specific maturation of the major histocompatibility antigens in rats. Pediatr Surg Int 2002; 18: 640.
6. Statter MB, Foglia RP, Parks DE, et al. Fetal and postnatal testis shows immunoprivilege as donor tissue. J Urol 1988; 139: 204.
7. Mandel TE. Fetal islet xenotransplantation in rodents and primates. JMolMed (Berlin, Germany) 1999; 77: 155.
8. Mandel TE. Fetal islet transplantation. Transplant Proc 1992; 24: 1996.
9. Aronovich A, Tchorsh D, Katchman H, et al. Correction of hemophilia as a proof of concept for treatment of monogenic diseases by fetal spleen transplantation. Proc Natl AcadSci USA2006; 103: 19075.
10. Eventov-Friedman S, Katchman H, Shezen E, et al. Embryonic pig liver, pancreas, and lung as a source for transplantation: Optimal organogenesis without teratoma depends on distinct time windows. Proc Natl Acad Sci USA 2005; 102: 2928.
11. Eventov-Friedman S, Tchorsh D, Katchman H, et al. Embryonic pig pancreatic tissue transplantation for the treatment of diabetes. PLoS Med 2006; 3: e215.
12. Katchman H, Tal O, Eventov-Friedman S, et al. Embryonic porcine liver as a source for transplantation: Advantage of intact liver implants over isolated hepatoblasts in overcoming homeostatic inhibition by the quiescent host liver. Stem Cells (Dayton, Ohio) 2008; 26: 1347.
13. Tchorsh-Yutsis D, Hecht G, Aronovich A, et al. Pig embryonic pancreatic tissue as a source for transplantation in diabetes: Transient treatment with anti-LFA1, anti-CD48 and FTY720 enables long term graft maintenance in mice with only mild ongoing immunosuppression. Diabetes 2009; 58: 1585.
14. Hecht G, Eventov-Friedman S, Rosen C, et al. Embryonic pig pancreatic tissue for the treatment of diabetes in a nonhuman primate model. Proc Natl Acad Sci USA 2009; 106: 8659.
15. RigbyMR, Trexler AM, Pearson TC, et al. CD28/CD154 blockade prevents autoimmune diabetes by inducing nondeletional tolerance after effector t-cell inhibition and regulatory T-cell expansion. Diabetes 2008; 57: 2672.
16. Oderup C, Malm H, Ekberg H, et al. Costimulation blockade-induced cardiac allograft tolerance: Inhibition of T cell expansion and accumulation of intragraft cD4( + )Foxp3( + ) T cells. Transplantation 2006; 82: 1493.
17. Guo L, Fujino M, Kimura H, et al. Simultaneous blockade of co-stimulatory signals, CD28 and ICOS, induced a stable tolerance in rat heart transplantation. Transplant Immunol 2003; 12: 41.
18. Steiner D, Brunicki N, Bachar-Lustig E, et al. Overcoming T cell-mediated rejection of bone marrow allografts by T-regulatory cells: Synergism with veto cells and rapamycin. Exp Hematol 2006; 34: 802.
19. Steiner D, Brunicki N, Blazar BR, et al. Tolerance induction by third-party "off-the-shelf CD4 + CD25+ Treg cells. Exp Hematol 2006; 34: 66.
20. Zeiser R, Leveson-Gower DB, Zambricki EA, et al. Differential impact of mammalian target of rapamycin inhibition on CD4+ CD25+Foxp3+ regulatory T cells compared with conventional CD4+ T cells. Blood 2008; 111: 453.
21. Pinschewer DD, Ochsenbein AF, Odermatt B, et al. FTY720 immunosuppression impairs effector T cell peripheral homing without affecting induction, expansion, and memory. J Immunol 2000; 164: 5761.
22. Sehgal SN. Rapamune (RAPA, rapamycin, sirolimus): Mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression. Clin Biochem 1998; 31: 335.
23. Sawicka E, Dubois G, Jarai G, et al. The sphingosine 1-phosphate receptor agonist FTY720 differentially affects the sequestration of CD4+/ CD25+ T-regulatory cells and enhances their functional activity. JIm-munol2005; 175: 7973.
24. Tang Q, Henriksen KJ, Bi M, et al. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J Exp Med 2004; 199: 1455.
25. Bluestone JA, Tang Q. Therapeutic vaccination using CD4+CD25 + antigen-specific regulatory T cells. Proc Natl Acad Sci USA 2004; 101(suppl2): 14622.
26. Mutis T, van Rijn RS, Simonetti ER, et al. Human regulatory T cells control xenogeneic graft-versus-host disease induced by autologous t cells in RAG2-/- yc-/- immunodeficient mice. Clin Cancer Res 2006; 12:5520.
27. Golovina TN, Mikheeva T, Suhoski MM, et al. CD28 costimulation is essential for human T regulatory expansion and function. J Immunol 2008; 181: 2855.
28. Zanin-Zhorov A, Cahalon L, Tal G, et al. Heat shock protein 60 enhances CD4+ CD25+ regulatory T cell function via innate TLR2 signaling. J Clin Invest 2006; 116: 2022.
29. Webster KE, Walters S, Kohler RE, et al. In vivo expansion of T reg cells with IL-2-mAb complexes: Induction of resistance to EAE and longterm acceptance of islet allografts without immunosuppression. J Exp Med 2009; 206: 751.
30. Tao R, de Zoeten EF, Ö zkaynak E, et al. Deacetylase inhibition promotes the generation and function of regulatory T cells. Nat Med 2007; 13: 1299.
31. Kalchenko V, Shivtiel S, Malina V, et al. Use of lipophilic near-infrared dye in whole-body optical imaging of hematopoietic cell homing. J Biomed Optics 2006; 11: 050507.